{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:11:58Z","timestamp":1792714318425,"version":"4.5.0"},"reference-count":178,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017638","name":"Ministry of Health of the Russian Federation","doi-asserted-by":"publisher","award":["124021400005-3"],"award-info":[{"award-number":["124021400005-3"]}],"id":[{"id":"10.13039\/501100017638","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017638","name":"Ministry of Health of the Russian Federation","doi-asserted-by":"publisher","award":["22-75-10151"],"award-info":[{"award-number":["22-75-10151"]}],"id":[{"id":"10.13039\/501100017638","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"RSF","doi-asserted-by":"publisher","award":["124021400005-3"],"award-info":[{"award-number":["124021400005-3"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"RSF","doi-asserted-by":"publisher","award":["22-75-10151"],"award-info":[{"award-number":["22-75-10151"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Reactive oxygen species (ROS) play a key role in cancer progression and antitumor therapy. Glioblastoma is a highly heterogeneous tumor with different cell populations exhibiting various redox statuses. Elevated ROS levels in cancer cells promote tumor growth and simultaneously make them more sensitive to anticancer drugs, but further elevation leads to cell death and apoptosis. Meanwhile, various subsets of tumor cells, such a glioblastoma stem cells (GSC) or the cells in tumor microenvironment (TME), demonstrate adaptive mechanisms to excessive ROS production by developing effective antioxidant systems such as glutathione- and thioredoxin-dependent. GSCs demonstrate higher chemoresistance and lower ROS levels than other glioma cells, while TME cells create a pro-oxidative environment and have immunosuppressive effects. Both subpopulations have become an attractive target for developing therapies. Increased expression of thioredoxin reductase (TrxR) is often associated with tumor progression and poor patient survival. Various TrxR inhibitors have been investigated as potential anticancer therapies, including nitrosoureas, flavonoids and metallic complexes. Gold derivatives are irreversible inhibitors of TrxR. Among them, auranofin (AF), a selective TrxR inhibitor, has proven its effectiveness as a drug for the treatment of rheumatoid arthritis and its efficacy as an anticancer agent has been demonstrated in preclinical studies in vitro and in vivo. However, further clinical application of AF could be challenging due to the low solubility and insufficient delivery to glioblastoma. Different delivery strategies for hydrophobic drugs could be used to increase the concentration of AF in the brain. Combining different therapeutic approaches that affect the redox status of various glioma cell populations could become a new strategy for treating brain tumor diseases.<\/jats:p>","DOI":"10.3390\/ijms26052084","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T03:37:57Z","timestamp":1740627477000},"page":"2084","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Inhibition of Thioredoxin-Reductase by Auranofin as a Pro-Oxidant Anticancer Strategy for Glioblastoma: In Vitro and In Vivo Studies"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2434-2465","authenticated-orcid":false,"given":"Nelly","family":"Chmelyuk","sequence":"first","affiliation":[{"name":"Department of Synthetic Neurotechnologies, Pirogov Russian National Research Medical University, 117997 Moscow, Russia"},{"name":"Laboratory of Biomedical nanomaterials, National Research Technological University \u201cMISIS\u201d, Leninskiy Prospekt 4, 119049 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kordyukova","sequence":"additional","affiliation":[{"name":"Neurotechnology Laboratory, Federal Center of Brain Research and Neurotechnologies, Federal Medical Biological Agency, 117513 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1541-9480","authenticated-orcid":false,"given":"Maria","family":"Sorokina","sequence":"additional","affiliation":[{"name":"Department of Synthetic Neurotechnologies, Pirogov Russian National Research Medical University, 117997 Moscow, Russia"},{"name":"Neurotechnology Laboratory, Federal Center of Brain Research and Neurotechnologies, Federal Medical Biological Agency, 117513 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2994-4857","authenticated-orcid":false,"given":"Semyon","family":"Sinyavskiy","sequence":"additional","affiliation":[{"name":"Department of Synthetic Neurotechnologies, Pirogov Russian National Research Medical University, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2284-0576","authenticated-orcid":false,"given":"Valeriya","family":"Meshcheryakova","sequence":"additional","affiliation":[{"name":"Department of Synthetic Neurotechnologies, Pirogov Russian National Research Medical University, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vsevolod","family":"Belousov","sequence":"additional","affiliation":[{"name":"Department of Synthetic Neurotechnologies, Pirogov Russian National Research Medical University, 117997 Moscow, Russia"},{"name":"Neurotechnology Laboratory, Federal Center of Brain Research and Neurotechnologies, Federal Medical Biological Agency, 117513 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9139-3326","authenticated-orcid":false,"given":"Tatiana","family":"Abakumova","sequence":"additional","affiliation":[{"name":"Department of Synthetic Neurotechnologies, Pirogov Russian National Research Medical University, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.5603\/RPOR.a2022.0113","article-title":"Survival and Quality of Life Analysis in Glioblastoma Multiforme with Adjuvant Chemoradiotherapy: A Retrospective Study","volume":"27","author":"Mohammed","year":"2022","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Ye, X., Xiong, Z., Ihsan, A., Ares, I., Mart\u00ednez, M., Lopez-Torres, B., Mart\u00ednez-Larra\u00f1aga, M.-R., Anad\u00f3n, A., and Wang, X. (2023). Cancer Metabolism: The Role of ROS in DNA Damage and Induction of Apoptosis in Cancer Cells. Metabolites, 13.","DOI":"10.3390\/metabo13070796"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Pawlowska, E., Szczepanska, J., Szatkowska, M., and Blasiak, J. (2018). An Interplay between Senescence, Apoptosis and Autophagy in Glioblastoma Multiforme\u2014Role in Pathogenesis and Therapeutic Perspective. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19030889"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Lo Dico, A., Salvatore, D., Martelli, C., Ronchi, D., Diceglie, C., Lucignani, G., and Ottobrini, L. (2019). Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma. Cells, 8.","DOI":"10.3390\/cells8111315"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.freeradbiomed.2011.10.487","article-title":"Resveratrol Enhances the Therapeutic Effect of Temozolomide against Malignant Glioma in Vitro and in Vivo by Inhibiting Autophagy","volume":"52","author":"Lin","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Knizhnik, A.V., Roos, W.P., Nikolova, T., Quiros, S., Tomaszowski, K.-H., Christmann, M., and Kaina, B. (2013). Survival and Death Strategies in Glioma Cells: Autophagy, Senescence and Apoptosis Triggered by a Single Type of Temozolomide-Induced DNA Damage. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0055665"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2147\/JIR.S275595","article-title":"Reactive Oxygen Species: Drivers of Physiological and Pathological Processes","volume":"13","author":"Checa","year":"2020","journal-title":"J. Inflamm. Res."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Le Gal, K., Schmidt, E.E., and Sayin, V.I. (2021). Cellular Redox Homeostasis. Antioxidants, 10.","DOI":"10.3390\/antiox10091377"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","article-title":"Oxidative Stress in Cancer","volume":"38","author":"Hayes","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"16419","DOI":"10.1073\/pnas.0407396101","article-title":"Reversible Oxidation and Inactivation of the Tumor Suppressor PTEN in Cells Stimulated with Peptide Growth Factors","volume":"101","author":"Kwon","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5381692","DOI":"10.1155\/2019\/5381692","article-title":"Understanding of ROS-Inducing Strategy in Anticancer Therapy","volume":"2019","author":"Kim","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s12272-020-01205-6","article-title":"Potential Implications of Hydrogen Peroxide in the Pathogenesis and Therapeutic Strategies of Gliomas","volume":"43","author":"Zhou","year":"2020","journal-title":"Arch. Pharm. Res."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Hasan, A.A., Kalinina, E., Tatarskiy, V., and Shtil, A. (2022). The Thioredoxin System of Mammalian Cells and Its Modulators. Biomedicines, 10.","DOI":"10.3390\/biomedicines10071757"},{"key":"ref_14","first-page":"590808","article-title":"Thioredoxin System Regulation in the Central Nervous System: Experimental Models and Clinical Evidence","volume":"2014","author":"Gonsebatt","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6175804","DOI":"10.1155\/2019\/6175804","article-title":"ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells","volume":"2019","author":"Snezhkina","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Kennedy, L., Sandhu, J.K., Harper, M.-E., and Cuperlovic-Culf, M. (2020). Role of Glutathione in Cancer: From Mechanisms to Therapies. Biomolecules, 10.","DOI":"10.3390\/biom10101429"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0891-5849(98)00213-5","article-title":"Changes in Glutathione Status and the Antioxidant System in Blood and in Cancer Cells Associate with Tumour Growth in Vivo","volume":"26","author":"Navarro","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"ref_18","first-page":"e220023","article-title":"Glutathione in Cancer Progression and Chemoresistance: An Update","volume":"2023","author":"Tasso","year":"2023","journal-title":"Redox Exp. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.18632\/oncoscience.12","article-title":"Cross Talk between Two Antioxidant Systems, Thioredoxin and DJ-1: Consequences for Cancer","volume":"1","author":"Raninga","year":"2014","journal-title":"Oncoscience"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Seitz, R., T\u00fcmen, D., Kunst, C., Heumann, P., Schmid, S., Kandulski, A., M\u00fcller, M., and G\u00fclow, K. (2024). Exploring the Thioredoxin System as a Therapeutic Target in Cancer: Mechanisms and Implications. Antioxidants, 13.","DOI":"10.3390\/antiox13091078"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Jovanovi\u0107, M., Podolski-Reni\u0107, A., Krasavin, M., and Pe\u0161i\u0107, M. (2022). The Role of the Thioredoxin Detoxification System in Cancer Progression and Resistance. Front. Mol. Biosci., 9.","DOI":"10.3389\/fmolb.2022.883297"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e1505","DOI":"10.1038\/cddis.2014.465","article-title":"Glutathione Depletion Sensitizes Cisplatin- and Temozolomide-Resistant Glioma Cells in Vitro and in Vivo","volume":"5","author":"Rocha","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.3892\/or.2015.3712","article-title":"Erastin Sensitizes Glioblastoma Cells to Temozolomide by Restraining XCT and Cystathionine-\u03b3-Lyase Function","volume":"33","author":"Chen","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1007\/s12035-020-01928-z","article-title":"Thioredoxin System Protein Expression Is Associated with Poor Clinical Outcome in Adult and Paediatric Gliomas and Medulloblastomas","volume":"57","author":"Yao","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Jovanovi\u0107, M., Dragoj, M., Zhukovsky, D., Dar\u2019in, D., Krasavin, M., Pe\u0161i\u0107, M., and Podolski-Reni\u0107, A. (2020). Novel TrxR1 Inhibitors Show Potential for Glioma Treatment by Suppressing the Invasion and Sensitizing Glioma Cells to Chemotherapy. Front. Mol. Biosci., 7.","DOI":"10.3389\/fmolb.2020.586146"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1007\/s12035-022-02808-4","article-title":"Cytotoxic and Radiosensitising Effects of a Novel Thioredoxin Reductase Inhibitor in Brain Cancers","volume":"59","author":"Yao","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Ngo, V., and Duennwald, M.L. (2022). Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease. Antioxidants, 11.","DOI":"10.3390\/antiox11122345"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Almeida Lima, K., Osawa, I.Y.A., Ramalho, M.C.C., de Souza, I., Guedes, C.B., Souza Filho, C.H.D.D., Monteiro, L.K.S., Latancia, M.T., and Rocha, C.R.R. (2023). Temozolomide Resistance in Glioblastoma by NRF2: Protecting the Evil. Biomedicines, 11.","DOI":"10.3390\/biomedicines11041081"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Jaganjac, M., Milkovic, L., Sunjic, S.B., and Zarkovic, N. (2020). The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies. Antioxidants, 9.","DOI":"10.3390\/antiox9111151"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Rocha, C.R.R., Rocha, A.R., Silva, M.M., Gomes, L.R., Latancia, M.T., Andrade-Tomaz, M., de Souza, I., Monteiro, L.K.S., and Menck, C.F.M. (2020). Revealing Temozolomide Resistance Mechanisms via Genome-Wide CRISPR Libraries. Cells, 9.","DOI":"10.3390\/cells9122573"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3892\/or.2012.2115","article-title":"Knockdown of Nrf2 Enhances Autophagy Induced by Temozolomide in U251 Human Glioma Cell Line","volume":"29","author":"Zhou","year":"2013","journal-title":"Oncol. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"48081","DOI":"10.18632\/oncotarget.10129","article-title":"NRF2 and Glutathione Are Key Resistance Mediators to Temozolomide in Glioma and Melanoma Cells","volume":"7","author":"Rocha","year":"2016","journal-title":"Oncotarget"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3892\/or.2014.3320","article-title":"Knockdown of Nuclear Factor Erythroid 2-Related Factor 2 by Lentivirus Induces Differentiation of Glioma Stem-like Cells","volume":"32","author":"Zhu","year":"2014","journal-title":"Oncol. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"15178","DOI":"10.1073\/pnas.2036535100","article-title":"Cancerous Stem Cells Can Arise from Pediatric Brain Tumors","volume":"100","author":"Hemmati","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature03128","article-title":"Identification of Human Brain Tumour Initiating Cells","volume":"432","author":"Singh","year":"2004","journal-title":"Nature"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41420-024-01873-z","article-title":"CREB5 Promotes the Proliferation and Self-Renewal Ability of Glioma Stem Cells","volume":"10","author":"Kim","year":"2024","journal-title":"Cell Death Discov."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.gendis.2015.02.001","article-title":"Glioblastoma Stem Cells (GSCs) Epigenetic Plasticity and Interconversion between Differentiated Non-GSCs and GSCs","volume":"2","author":"Safa","year":"2015","journal-title":"Genes Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1586\/14737175.2015.1051968","article-title":"The Role of Glioma Stem Cells in Chemotherapy Resistance and Glioblastoma Multiforme Recurrence","volume":"15","author":"Auffinger","year":"2015","journal-title":"Expert Rev. Neurother."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Pasqualetti, F., Miniati, M., Gonnelli, A., Gadducci, G., Giannini, N., Palagini, L., Mancino, M., Fuentes, T., and Paiar, F. (2023). Cancer Stem Cells and Glioblastoma: Time for Innovative Biomarkers of Radio-Resistance?. Biology, 12.","DOI":"10.3390\/biology12101295"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e1601","DOI":"10.1038\/cddis.2014.566","article-title":"Reactive Oxygen Species-Mediated Therapeutic Response and Resistance in Glioblastoma","volume":"6","author":"Singer","year":"2015","journal-title":"Cell Death Dis."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Olivier, C., Oliver, L., Lalier, L., and Vallette, F.M. (2021). Drug Resistance in Glioblastoma: The Two Faces of Oxidative Stress. Front. Mol. Biosci., 7.","DOI":"10.3389\/fmolb.2020.620677"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"16062","DOI":"10.1073\/pnas.1106704108","article-title":"Metabolic State of Glioma Stem Cells and Nontumorigenic Cells","volume":"108","author":"Vlashi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_43","first-page":"1264","article-title":"Glutathione Peroxidase 4 Maintains a Stemness Phenotype, Oxidative Homeostasis and Regulates Biological Processes in Panc-1 Cancer Stem-like Cells","volume":"41","author":"Peng","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1158\/1078-0432.CCR-23-0493","article-title":"Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma","volume":"30","author":"Galbo","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"vdad009","DOI":"10.1093\/noajnl\/vdad009","article-title":"Tumor Microenvironment in Glioblastoma: Current and Emerging Concepts","volume":"5","author":"Sharma","year":"2023","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Weinberg, F., Ramnath, N., and Nagrath, D. (2019). Reactive Oxygen Species in the Tumor Microenvironment: An Overview. Cancers, 11.","DOI":"10.3390\/cancers11081191"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1158\/0008-5472.CAN-19-3158","article-title":"NOX4 Inhibition Potentiates Immunotherapy by Overcoming Cancer-Associated Fibroblast-Mediated CD8 T-Cell Exclusion from Tumors","volume":"80","author":"Ford","year":"2020","journal-title":"Cancer Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1158\/2326-6066.CIR-19-0507","article-title":"Cancer-Associated Fibroblasts Promote Immunosuppression by Inducing ROS-Generating Monocytic MDSCs in Lung Squamous Cell Carcinoma","volume":"8","author":"Xiang","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e1596004","DOI":"10.1080\/2162402X.2019.1596004","article-title":"Interaction of Tumor-Associated Macrophages and Cancer Chemotherapy","volume":"8","author":"Larionova","year":"2019","journal-title":"Oncoimmunology"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Ren, J., Xu, B., Ren, J., Liu, Z., Cai, L., Zhang, X., Wang, W., Li, S., Jin, L., and Ding, L. (2023). The Importance of M1-and M2-Polarized Macrophages in Glioma and as Potential Treatment Targets. Brain Sci., 13.","DOI":"10.3390\/brainsci13091269"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Kennel, K.B., and Greten, F.R. (2021). Immune Cell\u2014Produced ROS and Their Impact on Tumor Growth and Metastasis. Redox Biol., 42.","DOI":"10.1016\/j.redox.2021.101891"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Xing, J., Cai, H., Lin, Z., Zhao, L., Xu, H., Song, Y., Wang, Z., Liu, C., Hu, G., and Zheng, J. (2024). Examining the Function of Macrophage Oxidative Stress Response and Immune System in Glioblastoma Multiforme through Analysis of Single-Cell Transcriptomics. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1288137"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Kuo, C.-L., Ponneri Babuharisankar, A., Lin, Y.-C., Lien, H.-W., Lo, Y.K., Chou, H.-Y., Tangeda, V., Cheng, L.-C., Cheng, A.N., and Lee, A.Y.-L. (2022). Mitochondrial Oxidative Stress in the Tumor Microenvironment and Cancer Immunoescape: Foe or Friend?. J. Biomed. Sci., 29.","DOI":"10.1186\/s12929-022-00859-2"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"109802","DOI":"10.1016\/j.clim.2023.109802","article-title":"Oxidative Stress Is Involved in Immunosuppression and Macrophage Regulation in Glioblastoma","volume":"258","author":"Liang","year":"2024","journal-title":"Clin. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.1172\/JCI137585","article-title":"Thioredoxin Activity Confers Resistance against Oxidative Stress in Tumor-Infiltrating NK Cells","volume":"130","author":"Yang","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.cmet.2020.03.004","article-title":"Glutathione Restricts Serine Metabolism to Preserve Regulatory T Cell Function","volume":"31","author":"Kurniawan","year":"2020","journal-title":"Cell Metab."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e1027471","DOI":"10.1080\/2162402X.2015.1027471","article-title":"Thioredoxin Induces Tregs to Generate an Immunotolerant Tumor Microenvironment in Metastatic Melanoma","volume":"4","author":"Wang","year":"2015","journal-title":"Oncoimmunology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0167-4889(90)90199-N","article-title":"The Mechanism of Action of the Nitrosourea Anti-Tumor Drugs on Thioredoxin Reductase, Glutathione Reductase and Ribonucleotide Reductase","volume":"1054","author":"Schallreuter","year":"1990","journal-title":"Biochim. Biophys. Acta-Mol. Cell Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.freeradbiomed.2005.04.025","article-title":"Inhibition of Thioredoxin Reductase but Not of Glutathione Reductase by the Major Classes of Alkylating and Platinum-Containing Anticancer Compounds","volume":"39","author":"Witte","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cbi.2006.04.008","article-title":"Cyclophosphamide Suppresses Thioredoxin Reductase in Bladder Tissue and Its Adaptive Response via Inductions of Thioredoxin Reductase and Glutathione Peroxidase","volume":"162","author":"Zhang","year":"2006","journal-title":"Chem. Biol. Interact."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.taap.2006.10.029","article-title":"Cyclophosphamide as a Potent Inhibitor of Tumor Thioredoxin Reductase in Vivo","volume":"218","author":"Wang","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"12288","DOI":"10.1073\/pnas.0701549104","article-title":"Targeting Thioredoxin Reductase Is a Basis for Cancer Therapy by Arsenic Trioxide","volume":"104","author":"Lu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s41420-023-01558-z","article-title":"An Overview of Arsenic Trioxide-Involved Combined Treatment Algorithms for Leukemia: Basic Concepts and Clinical Implications","volume":"9","author":"Jiang","year":"2023","journal-title":"Cell Death Discov."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.toxlet.2013.03.019","article-title":"Arsenic Trioxide Depletes Cancer Stem-like Cells and Inhibits Repopulation of Neurosphere Derived from Glioblastoma by Downregulation of Notch Pathway","volume":"220","author":"Wu","year":"2013","journal-title":"Toxicol. Lett."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/jcb.20102","article-title":"Inhibition of Cell Proliferation and the Action Mechanisms of Arsenic Trioxide (As2O3) on Human Breast Cancer Cells","volume":"93","author":"Chow","year":"2004","journal-title":"J. Cell. Biochem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1002\/jcb.24230","article-title":"Arsenic Trioxide Induces G2\/M Arrest in Hepatocellular Carcinoma Cells by Increasing the Tumor Suppressor PTEN Expression","volume":"113","author":"Yang","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"ref_67","first-page":"1","article-title":"Evaluation of Arsenic Trioxide Potential for Lung Cancer Treatment: Assessment of Apoptotic Mechanisms and Oxidative Damage","volume":"8","author":"Walker","year":"2015","journal-title":"J. Cancer Sci. Ther."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.trsl.2022.11.007","article-title":"Arsenic Trioxide Sensitizes Pancreatic Cancer Cells to Gemcitabine through Downregulation of the TIMP1\/PI3K\/AKT\/MTOR Axis","volume":"255","author":"Tian","year":"2023","journal-title":"Transl. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"vdae089","DOI":"10.1093\/noajnl\/vdae089","article-title":"Phase I and Pharmacodynamic Study of Arsenic Trioxide plus Radiotherapy in Patients with Newly Diagnosed Glioblastoma","volume":"6","author":"Ryu","year":"2024","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_70","first-page":"739","article-title":"A Phase I Single-Dose Trial of Gadolinium Texaphyrin (Gd-Tex), a Tumor Selective Radiation Sensitizer Detectable by Magnetic Resonance Imaging","volume":"5","author":"Rosenthal","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1073\/pnas.93.13.6610","article-title":"Gadolinium(III) Texaphyrin: A Tumor Selective Radiation Sensitizer That Is Detectable by MRI","volume":"93","author":"Young","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"10691","DOI":"10.1074\/jbc.M511373200","article-title":"Motexafin Gadolinium, a Tumor-Selective Drug Targeting Thioredoxin Reductase and Ribonucleotide Reductase","volume":"281","author":"Hashemy","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.ijrobp.2008.05.068","article-title":"Motexafin Gadolinium Combined With Prompt Whole Brain Radiotherapy Prolongs Time to Neurologic Progression in Non\u2013Small-Cell Lung Cancer Patients With Brain Metastases: Results of a Phase III Trial","volume":"73","author":"Mehta","year":"2009","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11172-022-3431-4","article-title":"Natural Compounds as Inhibitors of Thioredoxin Reductase (TrxR1)","volume":"71","author":"Chupakhin","year":"2022","journal-title":"Russ. Chem. Bull."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"25284","DOI":"10.1074\/jbc.M414645200","article-title":"Thioredoxin Reductase Is Irreversibly Modified by Curcumin","volume":"280","author":"Fang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.taap.2012.05.012","article-title":"Curcumin Targeting the Thioredoxin System Elevates Oxidative Stress in HeLa Cells","volume":"262","author":"Cai","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Larasati, Y.A., Yoneda-Kato, N., Nakamae, I., Yokoyama, T., Meiyanto, E., and Kato, J. (2018). Curcumin Targets Multiple Enzymes Involved in the ROS Metabolic Pathway to Suppress Tumor Cell Growth. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-20179-6"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Zhang, Q., Chen, W., Lv, X., Weng, Q., Chen, M., Cui, R., Liang, G., and Ji, J. (2019). Piperlongumine, a Novel TrxR1 Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cells by ROS-Mediated ER Stress. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.01180"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.freeradbiomed.2010.09.008","article-title":"Noble Metal Targeting of Thioredoxin Reductase\u2014Covalent Complexes with Thioredoxin and Thioredoxin-Related Protein of 14 kDa Triggered by Cisplatin","volume":"49","author":"Cebula","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Cheng, P., Liu, H., Li, Y., Pi, P., Jiang, Y., Zang, S., Li, X., Fu, A., Ren, X., and Xu, J. (2020). Inhibition of Thioredoxin Reductase 1 Correlates with Platinum-Based Chemotherapeutic Induced Tissue Injury. Biochem. Pharmacol., 175.","DOI":"10.1016\/j.bcp.2020.113873"},{"key":"ref_81","first-page":"1","article-title":"Auranofin and Its Analogs as Prospective Agents for the Treatment of Colorectal Cancer","volume":"5","author":"Massai","year":"2022","journal-title":"Cancer Drug Resist."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s10534-010-9367-4","article-title":"In Vivo and in Vitro Inhibition of Mice Thioredoxin Reductase by Methylmercury","volume":"23","author":"Wagner","year":"2010","journal-title":"BioMetals"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.taap.2010.12.005","article-title":"Inhibition of the Thioredoxin System in the Brain and Liver of Zebra-Seabreams Exposed to Waterborne Methylmercury","volume":"251","author":"Branco","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.tiv.2006.01.012","article-title":"Sublethal Concentrations of Diverse Gold Compounds Inhibit Mammalian Cytosolic Thioredoxin Reductase (TrxR1)","volume":"20","author":"Omata","year":"2006","journal-title":"Toxicol. Vitr."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.bcp.2007.07.022","article-title":"A Gold(I) Phosphine Complex Selectively Induces Apoptosis in Breast Cancer Cells: Implications for Anticancer Therapeutics Targeted to Mitochondria","volume":"74","author":"Rackham","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"8895","DOI":"10.1002\/anie.201202939","article-title":"On the Biological Properties of Alkynyl Phosphine Gold(I) Complexes","volume":"51","author":"Meyer","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/anie.200502756","article-title":"Undressing of Phosphine Gold(I) Complexes as Irreversible Inhibitors of Human Disulfide Reductases","volume":"45","author":"Urig","year":"2006","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1021\/ic403011h","article-title":"Caffeine-Based Gold(I) N -Heterocyclic Carbenes as Possible Anticancer Agents: Synthesis and Biological Properties","volume":"53","author":"Bertrand","year":"2014","journal-title":"Inorg. Chem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"8608","DOI":"10.1021\/jm100801e","article-title":"Benzimidazol-2-Ylidene Gold(I) Complexes Are Thioredoxin Reductase Inhibitors with Multiple Antitumor Properties","volume":"53","author":"Rubbiani","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1039\/c8mt00306h","article-title":"A Gold (i) Biscarbene Complex with Improved Activity as a TrxR Inhibitor and Cytotoxic Drug: Comparative Studies with Different Gold Metallodrugs","volume":"11","author":"Schmidt","year":"2019","journal-title":"Metallomics"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1039\/c2dt11781a","article-title":"Synthesis and Characterization of Azolate Gold(i) Phosphane Complexes as Thioredoxin Reductase Inhibiting Antitumor Agents","volume":"41","author":"Galassi","year":"2012","journal-title":"Dalt. Trans."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1039\/C4DT03105A","article-title":"Gold(I) Thiotetrazolates as Thioredoxin Reductase Inhibitors and Antiproliferative Agents","volume":"44","author":"Serebryanskaya","year":"2015","journal-title":"Dalt. Trans."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1016\/0006-2952(86)90608-8","article-title":"Cellular and Molecular Pharmacology of Auranofin and Related Gold Complexes","volume":"35","author":"Crooke","year":"1986","journal-title":"Biochem. Pharmacol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bcp.2017.09.009","article-title":"Selective Inhibition of Endogenous Antioxidants with Auranofin Causes Mitochondrial Oxidative Stress Which Can Be Countered by Selenium Supplementation","volume":"146","author":"Radenkovic","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Salmain, M., Gaschard, M., Baroud, M., Lepeltier, E., Jaouen, G., Passirani, C., and Vessi\u00e8res, A. (2023). Thioredoxin Reductase and Organometallic Complexes: A Pivotal System to Tackle Multidrug Resistant Tumors?. Cancers, 15.","DOI":"10.3390\/cancers15184448"},{"key":"ref_96","first-page":"5486","article-title":"In Vivo Antitumor Activity and in Vitro Cytotoxic Properties of Bis [1,2-Bis(Diphenylphosphino)Ethane]Gold(I) Chloride","volume":"46","author":"Mirabelli","year":"1986","journal-title":"Cancer Res."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Wang, S., Lu, Y., Woods, K., Di Trapani, G., and Tonissen, K.F. (2021). Investigating the Thioredoxin and Glutathione Systems\u2019 Response in Lymphoma Cells after Treatment with [Au(D2pype)2]Cl. Antioxidants, 10.","DOI":"10.3390\/antiox10010104"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Sze, J.H., Raninga, P.V., Nakamura, K., Casey, M., Khanna, K.K., Berners-Price, S.J., Di Trapani, G., and Tonissen, K.F. (2020). Anticancer Activity of a Gold(I) Phosphine Thioredoxin Reductase Inhibitor in Multiple Myeloma. Redox Biol., 28.","DOI":"10.1016\/j.redox.2019.101310"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Clapper, E., Wang, S., Raninga, P.V., Di Trapani, G., and Tonissen, K.F. (2020). Cross-Talk between Bcr-Abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment. Antioxidants, 9.","DOI":"10.3390\/antiox9030207"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/cmdc.200900370","article-title":"Anticancer Therapeutics That Target Selenoenzymes: Synthesis, Characterization, in Vitro Cytotoxicity, and Thioredoxin Reductase Inhibition of a Series of Gold(I) Complexes Containing Hydrophilic Phosphine Ligands","volume":"5","author":"Vergara","year":"2010","journal-title":"ChemMedChem"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.leukres.2010.05.011","article-title":"The Gold Compound Auranofin Induces Apoptosis of Human Multiple Myeloma Cells through Both Down-Regulation of STAT3 and Inhibition of NF-\u039aB Activity","volume":"35","author":"Nakaya","year":"2011","journal-title":"Leuk. Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1073\/pnas.102181599","article-title":"Human Chronic Lymphocytic Leukemia Modeled in Mouse by Targeted TCL1 Expression","volume":"99","author":"Bichi","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"9118","DOI":"10.18632\/oncotarget.2361","article-title":"Anti-Rheumatic Agent Auranofin Induced Apoptosis in Chronic Myeloid Leukemia Cells Resistant to Imatinib through Both Bcr\/Abl-Dependent and -Independent Mechanisms","volume":"5","author":"Chen","year":"2014","journal-title":"Oncotarget"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1158\/2326-6066.CIR-13-0127","article-title":"PD-L1 Expression in Triple-Negative Breast Cancer","volume":"2","author":"Mittendorf","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.redox.2015.06.004","article-title":"Disruption of Thioredoxin Metabolism Enhances the Toxicity of Transforming Growth Factor \u03b2-Activated Kinase 1 (TAK1) Inhibition in KRAS-Mutated Colon Cancer Cells","volume":"5","author":"Hrabe","year":"2015","journal-title":"Redox Biol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/med.21872","article-title":"Upgrade of an Old Drug: Auranofin in Innovative Cancer Therapies to Overcome Drug Resistance and to Increase Drug Effectiveness","volume":"42","author":"Gamberi","year":"2022","journal-title":"Med. Res. Rev."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Freire Boullosa, L., Van Loenhout, J., Hermans, C., Lau, H.W., Merlin, C., Marcq, E., Takhsha, F.S., Martinet, W., De Meyer, G.R.Y., and Lardon, F. (2022). Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14122761"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.7150\/thno.72248","article-title":"Targeting the Splicing Factor NONO Inhibits GBM Progression through GPX1 Intron Retention","volume":"12","author":"Wang","year":"2022","journal-title":"Theranostics"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"21496","DOI":"10.1074\/jbc.M116.734756","article-title":"Therapeutic Strategy for Targeting Aggressive Malignant Gliomas by Disrupting Their Energy Balance","volume":"291","author":"Hegazy","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"110054","DOI":"10.1016\/j.celrep.2021.110054","article-title":"Protein Kinase C\u03b9 and SRC Signaling Define Reciprocally Related Subgroups of Glioblastoma with Distinct Therapeutic Vulnerabilities","volume":"37","author":"Kenchappa","year":"2021","journal-title":"Cell Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.sopen.2019.05.004","article-title":"Antineoplastic Effects of Auranofin in Human Pancreatic Adenocarcinoma Preclinical Models","volume":"1","author":"Roife","year":"2019","journal-title":"Surg. Open Sci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41419-017-0159-4","article-title":"Elimination of Stem-like Cancer Cell Side-Population by Auranofin through Modulation of ROS and Glycolysis","volume":"9","author":"Hou","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Yang, M., Liu, J., Li, J., Wen, S., Hu, Y., Lu, W., Liu, J., Huang, P., and Liu, P. (2024). The Rheumatoid Arthritis Drug Auranofin Exerts Potent Anti-Lymphoma Effect by Stimulating TXNRD-Mediated ROS Generation and Inhibition of Energy Metabolism. Redox Biol., 75.","DOI":"10.1016\/j.redox.2024.103245"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"101004","DOI":"10.1016\/j.neo.2024.101004","article-title":"Inducing Ubiquitination and Degradation of TrxR1 Protein by LW-216 Promotes Apoptosis in Non-Small Cell Lung Cancer via Triggering ROS Production","volume":"53","author":"Wang","year":"2024","journal-title":"Neoplasia"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"16678","DOI":"10.1074\/jbc.RA120.013893","article-title":"Human Pancreatic Cancer Cells under Nutrient Deprivation Are Vulnerable to Redox System Inhibition","volume":"295","author":"Onodera","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"36505","DOI":"10.18632\/oncotarget.5364","article-title":"Auranofin Induces Apoptosis by ROS-Mediated ER Stress and Mitochondrial Dysfunction and Displayed Synergistic Lethality with Piperlongumine in Gastric Cancer","volume":"6","author":"Zou","year":"2015","journal-title":"Oncotarget"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Van Loenhout, J., Freire Boullosa, L., Quatannens, D., De Waele, J., Merlin, C., Lambrechts, H., Lau, H.W., Hermans, C., Lin, A., and Lardon, F. (2021). Auranofin and Cold Atmospheric Plasma Synergize to Trigger Distinct Cell Death Mechanisms and Immunogenic Responses in Glioblastoma. Cells, 10.","DOI":"10.3390\/cells10112936"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Han, Y., Chen, P., Zhang, Y., Lu, W., Ding, W., Luo, Y., Wen, S., Xu, R., Liu, P., and Huang, P. (2019). Synergy between Auranofin and Celecoxib against Colon Cancer In Vitro and In Vivo through a Novel Redox-Mediated Mechanism. Cancers, 11.","DOI":"10.3390\/cancers11070931"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.1158\/1078-0432.CCR-11-0736","article-title":"Enhancement of Carboplatin-Mediated Lung Cancer Cell Killing by Simultaneous Disruption of Glutathione and Thioredoxin Metabolism","volume":"17","author":"Fath","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1007\/s10637-019-00750-2","article-title":"A High-Throughput Drug Screen Identifies Auranofin as a Potential Sensitizer of Cisplatin in Small Cell Lung Cancer","volume":"37","author":"Liu","year":"2019","journal-title":"Investig. New Drugs"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.18632\/oncotarget.13385","article-title":"In Silico and in Vitro Drug Screening Identifies New Therapeutic Approaches for Ewing Sarcoma","volume":"8","author":"Pessetto","year":"2017","journal-title":"Oncotarget"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.canlet.2019.11.042","article-title":"FoxO3 Reverses 5-Fluorouracil Resistance in Human Colorectal Cancer Cells by Inhibiting the Nrf2\/TR1 Signaling Pathway","volume":"470","author":"Liu","year":"2020","journal-title":"Cancer Lett."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e1191","DOI":"10.1038\/cddis.2014.132","article-title":"Enhancement of Auranofin-Induced Lung Cancer Cell Apoptosis by Selenocystine, a Natural Inhibitor of TrxR1 in Vitro and in Vivo","volume":"5","author":"Fan","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.18632\/oncotarget.6516","article-title":"Auranofin-Mediated Inhibition of PI3K\/AKT\/MTOR Axis and Anticancer Activity in Non-Small Cell Lung Cancer Cells","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1158\/1078-0432.CCR-18-2751","article-title":"Auranofin Protects Intestine against Radiation Injury by Modulating P53\/P21 Pathway and Radiosensitizes Human Colon Tumor","volume":"25","author":"Nag","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1158\/0008-5472.CAN-13-2033","article-title":"Auranofin Induces Lethal Oxidative and Endoplasmic Reticulum Stress and Exerts Potent Preclinical Activity against Chronic Lymphocytic Leukemia","volume":"74","author":"Fiskus","year":"2014","journal-title":"Cancer Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s10534-013-9639-x","article-title":"N(4)-Tolyl-2-Acetylpyridine Thiosemicarbazones and Their Platinum(II,IV) and Gold(III) Complexes: Cytotoxicity against Human Glioma Cells and Studies on the Mode of Action","volume":"26","author":"Ferraz","year":"2013","journal-title":"BioMetals"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Jamali, F., Lan, K., Daniel, P., Petrecca, K., Sabri, S., and Abdulkarim, B. (2024). Synergistic Dual Targeting of Thioredoxin and Glutathione Systems Irrespective of P53 in Glioblastoma Stem Cells. Antioxidants, 13.","DOI":"10.20944\/preprints202409.0790.v1"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Szeliga, M., and Rola, R. (2022). Menadione Potentiates Auranofin-Induced Glioblastoma Cell Death. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232415712"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Martinez-Jaramillo, E., Jamali, F., Abdalbari, F.H., Abdulkarim, B., Jean-Claude, B.J., Telleria, C.M., and Sabri, S. (2024). Pro-Oxidant Auranofin and Glutathione-Depleting Combination Unveils Synergistic Lethality in Glioblastoma Cells with Aberrant Epidermal Growth Factor Receptor Expression. Cancers, 16.","DOI":"10.3390\/cancers16132319"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/ard.35.3.251","article-title":"Auranofin. New Oral Gold Compound for Treatment of Rheumatoid Arthritis","volume":"35","author":"Finkelstein","year":"1976","journal-title":"Ann. Rheum. Dis."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"20096","DOI":"10.1074\/jbc.273.32.20096","article-title":"Human Placenta Thioredoxin Reductase","volume":"273","author":"Gromer","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev.biophys.30.1.421","article-title":"Properties and Biological Activities of Thioredoxins","volume":"30","author":"Powis","year":"2001","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3390\/cancers2020209","article-title":"Thioredoxin and Cancer: A Role for Thioredoxin in All States of Tumor Oxygenation","volume":"2","author":"Karlenius","year":"2010","journal-title":"Cancers"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1248\/cpb.c18-00767","article-title":"Potential Anticancer Activity of Auranofin","volume":"67","author":"Onodera","year":"2019","journal-title":"Chem. Pharm. Bull."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1089\/ars.2013.5499","article-title":"Glutaredoxin 2 Reduces Both Thioredoxin 2 and Thioredoxin 1 and Protects Cells from Apoptosis Induced by Auranofin and 4-Hydroxynonenal","volume":"21","author":"Zhang","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Liu, X., Zhang, Y., Lu, W., Han, Y., Yang, J., Jiang, W., You, X., Luo, Y., Wen, S., and Hu, Y. (2020). Mitochondrial TXNRD3 Confers Drug Resistance via Redox-Mediated Mechanism and Is a Potential Therapeutic Target in Vivo. Redox Biol., 36.","DOI":"10.1016\/j.redox.2020.101652"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.canlet.2005.05.010","article-title":"A Thioredoxin Reductase Inhibitor Induces Growth Inhibition and Apoptosis in Five Cultured Human Carcinoma Cell Lines","volume":"236","author":"Zhao","year":"2006","journal-title":"Cancer Lett."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.freeradbiomed.2009.08.015","article-title":"The Effects of Hexavalent Chromium on Thioredoxin Reductase and Peroxiredoxins in Human Bronchial Epithelial Cells","volume":"47","author":"Myers","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.freeradbiomed.2009.09.016","article-title":"High Levels of Thioredoxin Reductase 1 Modulate Drug-Specific Cytotoxic Efficacy","volume":"47","author":"Eriksson","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1093\/carcin\/bgl111","article-title":"Thioredoxin Reductase Is Required for the Inactivation of Tumor Suppressor P53 and for Apoptosis Induced by Endogenous Electrophiles","volume":"27","author":"Cassidy","year":"2006","journal-title":"Carcinogenesis"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Anest\u00e5l, K., Prast-Nielsen, S., Cenas, N., and Arn\u00e9r, E.S.J. (2008). Cell Death by SecTRAPs: Thioredoxin Reductase as a Prooxidant Killer of Cells. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0001846"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-5793(94)01368-B","article-title":"Persistent Oxidative Stress in Cancer","volume":"358","author":"Toyokuni","year":"1995","journal-title":"FEBS Lett."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting Cancer Cells by ROS-Mediated Mechanisms: A Radical Therapeutic Approach?","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13045-023-01513-6","article-title":"Direct Inhibition of Dioxygenases TET1 by the Rheumatoid Arthritis Drug Auranofin Selectively Induces Cancer Cell Death in T-ALL","volume":"16","author":"Chen","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.4049\/jimmunol.164.11.5981","article-title":"Thiol-Reactive Metal Compounds Inhibit NF-\u039aB Activation by Blocking I\u03baB Kinase","volume":"164","author":"Jeon","year":"2000","journal-title":"J. Immunol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/wsbm.1331","article-title":"Signaling via the NF\u03baB System","volume":"8","author":"Mitchell","year":"2016","journal-title":"WIREs Syst. Biol. Med."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0092-8674(04)00302-2","article-title":"I\u03baB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a","volume":"117","author":"Hu","year":"2004","journal-title":"Cell"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.18632\/oncotarget.2113","article-title":"Clinically Used Antirheumatic Agent Auranofin Is a Proteasomal Deubiquitinase Inhibitor and Inhibits Tumor Growth","volume":"5","author":"Liu","year":"2014","journal-title":"Oncotarget"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.18632\/oncotarget.6425","article-title":"Two Clinical Drugs Deubiquitinase Inhibitor Auranofin and Aldehyde Dehydrogenase Inhibitor Disulfiram Trigger Synergistic Anti-Tumor Effects in Vitro and in Vivo","volume":"7","author":"Huang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.biochi.2019.03.015","article-title":"Repurposing of Auranofin: Thioredoxin Reductase Remains a Primary Target of the Drug","volume":"162","author":"Zhang","year":"2019","journal-title":"Biochimie"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1158\/1541-7786.MCR-13-0371-T","article-title":"PKC\u03b9 Maintains a Tumor-Initiating Cell Phenotype That Is Required for Ovarian Tumorigenesis","volume":"11","author":"Wang","year":"2013","journal-title":"Mol. Cancer Res."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"28450","DOI":"10.1074\/jbc.M606054200","article-title":"Aurothiomalate Inhibits Transformed Growth by Targeting the PB1 Domain of Protein Kinase C\u03b9","volume":"281","author":"Erdogan","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/jcp.22463","article-title":"Protein Kinase C\u03b9 Expression and Oncogenic Signaling Mechanisms in Cancer","volume":"226","author":"Murray","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13046-015-0275-x","article-title":"New Trends for Overcoming ABCG2\/BCRP-Mediated Resistance to Cancer Therapies","volume":"34","author":"Westover","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"215026","DOI":"10.1016\/j.ccr.2023.215026","article-title":"Metallodrug Binding to Serum Albumin: Lessons from Biophysical and Structural Studies","volume":"480","author":"Merlino","year":"2023","journal-title":"Coord. Chem. Rev."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/B:PHAM.0000016235.32639.23","article-title":"Solubilizing Excipients in Oral and Injectable Formulations","volume":"21","author":"Strickley","year":"2004","journal-title":"Pharm. Res."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Afzalipour, R., Khoei, S., Khoee, S., Shirvalilou, S., Raoufi, N.J., Motevalian, M., and Karimi, M.Y. (2021). Thermosensitive Magnetic Nanoparticles Exposed to Alternating Magnetic Field and Heat-Mediated Chemotherapy for an Effective Dual Therapy in Rat Glioma Model. Nanomed. Nanotechnol. Biol. Med., 31.","DOI":"10.1016\/j.nano.2020.102319"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jcis.2022.07.025","article-title":"Transport of Cationic Liposomes in a Human Blood Brain Barrier Model: Role of the Stereochemistry of the Gemini Amphiphile on Liposome Biological Features","volume":"627","author":"Simonis","year":"2022","journal-title":"J. Colloid Interface Sci."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1021\/acsabm.4c00184","article-title":"Auranofin-Loaded Chitosan Nanoparticles Demonstrate Potency against Triple-Negative Breast Cancer","volume":"7","author":"Afrifa","year":"2024","journal-title":"ACS Appl. Bio Mater."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Lloret, M., Reidy, E., Lozano-P\u00e9rez, A.A., Marchal, J.A., Lens, P.N.L., Ryan, A.E., and Erxleben, A. (2024). Auranofin Loaded Silk Fibroin Nanoparticles for Colorectal Cancer Treatment. Drug Deliv. Transl. Res.","DOI":"10.1007\/s13346-024-01719-2"},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"D\u00edez-Mart\u00ednez, R., Garc\u00eda-Fern\u00e1ndez, E., Manzano, M., Mart\u00ednez, \u00c1., Domenech, M., Vallet-Reg\u00ed, M., and Garc\u00eda, P. (2016). Auranofin-Loaded Nanoparticles as a New Therapeutic Tool to Fight Streptococcal Infections. Sci. Rep., 6.","DOI":"10.1038\/srep19525"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"10031","DOI":"10.1007\/s00210-024-03253-x","article-title":"Auranofin-Loaded PLGA Nanoparticles Alleviate Cognitive Deficit Induced by Streptozotocin in Rats Model: Modulation of Oxidative Stress, Neuroinflammatory Markers, and Neurotransmitters","volume":"397","author":"Kushawaha","year":"2024","journal-title":"Naunyn. Schmiedebergs. Arch. Pharmacol."},{"key":"ref_165","first-page":"252","article-title":"Drug Delivery to the Central Nervous System: A Review","volume":"6","author":"Misra","year":"2003","journal-title":"J. Pharm. Pharm. Sci."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1461-5347(00)00258-3","article-title":"Brain Drug Delivery Technologies: Novel Approaches for Transporting Therapeutics","volume":"3","author":"Temsamani","year":"2000","journal-title":"Pharm. Sci. Technol. Today"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/153303460500400409","article-title":"Novel Advances in Drug Delivery to Brain Cancer","volume":"4","author":"Lesniak","year":"2005","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.2174\/1381612043384826","article-title":"New Technologies for Drug Delivery Across the Blood Brain Barrier","volume":"10","author":"Kabanov","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"8511","DOI":"10.1016\/j.biomaterials.2013.07.075","article-title":"Transferrin-Conjugated Magnetic Silica PLGA Nanoparticles Loaded with Doxorubicin and Paclitaxel for Brain Glioma Treatment","volume":"34","author":"Cui","year":"2013","journal-title":"Biomaterials"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"10446","DOI":"10.18632\/oncotarget.2182","article-title":"Medical Treatment of Orthotopic Glioblastoma with Transferrin-Conjugated Nanoparticles Encapsulating Zoledronic Acid","volume":"5","author":"Porru","year":"2014","journal-title":"Oncotarget"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11910-024-01338-x","article-title":"Strategies to Improve Drug Delivery Across the Blood\u2013Brain Barrier for Glioblastoma","volume":"24","author":"Narsinh","year":"2024","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1007049806660","article-title":"Osmotic Opening of the Blood-Brain Barrier: Principles, Mechanism, and Therapeutic Applications","volume":"20","author":"Rapoport","year":"2000","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Dauba, A., Delalande, A., Kamimura, H.A.S., Conti, A., Larrat, B., Tsapis, N., and Novell, A. (2020). Recent Advances on Ultrasound Contrast Agents for Blood-Brain Barrier Opening with Focused Ultrasound. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12111125"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jconrel.2019.07.023","article-title":"Safety and Efficacy of Focused Ultrasound Induced Blood-Brain Barrier Opening, an Integrative Review of Animal and Human Studies","volume":"309","author":"Meng","year":"2019","journal-title":"J. Control. Release"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"115199","DOI":"10.1016\/j.addr.2024.115199","article-title":"From Concept to Early Clinical Trials: 30 Years of Microbubble-Based Ultrasound-Mediated Drug Delivery Research","volume":"206","author":"Bouakaz","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2017.03.017","article-title":"MR Image-Guided Delivery of Cisplatin-Loaded Brain-Penetrating Nanoparticles to Invasive Glioma with Focused Ultrasound","volume":"263","author":"Timbie","year":"2017","journal-title":"J. Control. Release"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1523\/JNEUROSCI.0899-17.2017","article-title":"DRG Voltage-Gated Sodium Channel 1.7 Is Upregulated in Paclitaxel-Induced Neuropathy in Rats and in Humans with Neuropathic Pain","volume":"38","author":"Li","year":"2018","journal-title":"J. Neurosci."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Wang, Y., Cao, B., Wang, Q., Fang, X., Wang, J., Chan, A.S.C., Xiong, X., and Zou, T. (2024). Ligand Supplementation Restores the Cancer Therapy Efficacy of an Antirheumatic Drug Auranofin from Serum Inactivation. bioRxiv.","DOI":"10.1101\/2024.01.25.577173"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/5\/2084\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:43:10Z","timestamp":1760028190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/5\/2084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":178,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["ijms26052084"],"URL":"https:\/\/doi.org\/10.3390\/ijms26052084","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]}}}